患有细胞癌和类细胞脱差异化 (ARON-1研究) 患者免疫组合的临床特征和反应

Chiara Ciccarese1, Thomas Büttner2, Linda Cerbone3

  • 1Medical Oncology Unit, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.

PubMed
概括

具有类特征的转移性细胞癌 (sRCC) 显示出侵略性行为. 基于免疫疗法的组合改善了sRCC患者的结果,无论它与其他免疫疗法或氨酸激酶抑制剂相结合.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K